Summary Cis-platinum (CDDP) induces severe inhibition of cell activation and cell cycle progression in PHA-stimulated human PBL's. Applying the novel BrdU/Hoechst flow cytometric technique for high resolution cell cycle analysis we show that CDDP induced multiple cell kinetic disturbances occur simultaneously comprising GO/Gl-arrest, and slow down and arrest of cells in S and G2/M-phase. We investigated whether the administration of reduced glutathione (GSH) might rescue cells from proliferative disturbances induced by CDDP. GSH at 0.15 mg ml-' only partially restored normal cell activation and cell cycle progression. However, at 1.5mgml-' a complete normal proliferation pattern was obtained. At the highest GSH dose rescue from inhibition of cell activation (GO/G1-phase arrest) as well as of cell cycle progression (S-and G2/M-phase arrest) was also present after delayed addition of GSH (1, 4 and 20 h) to CDDP treated PBL's. In addition cell viability of CDDP exposed PBL's is restored after GSH treatment. Our in vitro experiments give evidence that an increase of WBC found in CDDP/GSH treated patients has a real underlying cellular physiological mechanism protecting human peripheral lymphocytes from CDDP toxicity.
The clastogenic drug CDDP is widely used as antineoplastic agent in cancer therapy. It induces DNA-damage mainly via DNA-strand cross-links (Lippard, 1982) . However, due to its non-selective action on normal diploid and tumour cells CDDP induces severe side effects like nephrotoxicity and neurotoxicity. In addition leucopenia is observed in CDDP treated patients, although at a lower frequency in comparison to carboplatin (Canetta et al., 1985; Mangioni et al., 1989) .
The selective effect of clastogenic agents on tumour cells can be enhanced by chemoprotection (Lazo & Bahnson, 1989; Gandara et al., 1991) of the normal diploid cells via thiol-carrying molecules like diethyldithiocarbamate, thiourea, thiosulfate or cysteamine (Borch et al., 1990; Bodenner et al., 1986; Gringeri et al., 1988; Zwelling et al., 1979; Filipski et al., 1979; Markmann et al., 1985; Goel et al., 1989; Shrieve & Harris, 1982) . However, the therapeutic use of these chemoprotectors is limited by their toxicity. Recent reports indicate that in vivo administration of GSH (Meister & Anderson, 1983 ) might protect from CDDP induced toxic side effects without interferring with its antineoplastic action. In addition it was found that doses of GSH used in vivo were non-toxic as analysed by different serum parameters of nephrotoxicity and body weight (Zunino et al., 1983; Zunino et al., 1989; Oriana et al., 1987; Di Re et al., 1990) .
To clarify the cellular effects of CDDP and GSH we investigated the cell kinetic effects of cell activation in GO/ GI-phase and cell cycle progression through S-and G2/Mphases. In addition cell viability was monitored via flow cytometry. Many data are available on the proliferation of tumour cells or permanent cell lines treated with CDDP (Salles et al., 1983; Kanno et al., 1985; Sorenson & Eastman, 1988; Fujikane et al., 1989) . However, none of the analytical techniques used were sufficient to reveal the cellular effects induced at the single cell level in heterogenous responding in vitro cell populations. In this study we used a novel BrdU/ Hoechst flow cytometric analysis to evaluate the multiple cell kinetic effects of CDDP and GSH (Kubbies et al., 1989; Kubbies et al., 1990a; Kubbies, 1990b (Kubbies et al., 1989; Kubbies et al., 1990a; Kubbies, 1990b (Kubbies et al., 1987; Kubbies et al., 1989) . As shown in Figure 1 the BrdU/Hoechst flow cytometric analysis displays as many as three consecutive cell cycles, and reveals the proliferative heterogeneity of PHA-activated PBL's at a single time-point after CDDP and GSH treatment. This is achieved by continuous labelling of the cycling cells with BrdU, and the different quenching effect of the DNA ATbase pair specific Hoechst fluorochrome (Kubbies et al., 1989) . In addition, due to the knowledge of the number of cells having divided once, twice or three times after activation, for the first time the real percentages of non-cycling and cycling cells in different compartments can be calculated (dilution effect of the non-cycling or slowly cycling cells by the rapidly dividing ones). In addition to qualitative improvements of resolution of cell cycle kinetics the BrdU/ Hoechst analysis also shows lower variation in repeat experiments in comparison to conventional radioactive thymidine labelling technique (Rabinovitch, 1983) .
CDDP induced cell cycle disturbances Both processes, cell activation and cell cycle progression are affected by CDDP. As shown in Figure 1 in the control culture (panel a) cells moved from the 1st (G0/G1) into the 2nd (G1'), 3rd (G1") and 4th (G1"') cell cycle as indicated by their prominent G0-phase peaks. However, the non-activated GO/GI cell fraction increases from 31.9% (control) to 39.3%, 50.4% and 83. 1% at 0.3, 1.0 and 3.0 iLg ml1 I CDDP (panels c, e and g). In addition to alterations of the G0/G1 fraction there is also an increase of cells in the S-and G2/Mpopulations in the 1st cell cycle (cell cycle progression compartments) which is paralleled by the disappearance of cells in the 3rd G1"' phase (panel c). At lower CDDP concentrations the G2/M arrest and delay is more prominent, whereas it is maximal in S-phase at intermediate and highest CDDP concentrations, respectively. At 3.0 ,gml-l CDDP there is an almost complete inhibition of cell activation, and only 16.5% of cells proliferate into the early S-phase compartment ( Figure 1, panel g ).
The quantitative data from repeat experiments of CDDP treated PBL's are shown in Table I . It displays a significant increase of the non-cycling G0/Gl-population from 34.3 ± 2.7% (control) to 80.3 ± 6.0% (3.0 fig ml-' CDDP), indicating severe inhibition of cell activation due to CDDP (P <0.001). Table I also reveals an increase of G2/M-fractions from 1.4 ± 0.5% (control) to 11.8 ±1.9% (1.0 sg ml-' CDDP), and a subsequent dramatic decrease to 1.9 ± 2.4% at the highest CDDP concentration (P <0.001). On contrary the 1st cell cycle S-phase fractions increase continuously, and remain at high levels even at 3.0 jig ml-' CDDP. S-phase and G2/M-phase increase are indicator of severe cell cycle progression disturbances induced by CDDP in addition to cell activation inhibition.
The prominent cellular decay lanes in Figure 1 panel c, e and g (lower left corner, indicative of cell death) increase I 80.3 ± 6.0 17.8 ± 3.6 1.9 ± 2.4
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In comparison with Figure 2 , mean values and standard deviations are shown only for the highest GSH concentration. For simplicity only 1st cell cycle data (GO/GI cell activation compartment, S-and G2/M cell cycle progression compartments) are shown. Data evaluation and analysis was performed using the BrdU/Hoechst cell kinetic analysis (see Figure 1 ).
dramatically with increasing CDDP concentrations. On contrary only small nuclear decay lanes are present in the control culture which are due primarily to spontaneous cell death after several rounds of replication (exclusively from 3rd and 4th cycle cells Figure 1 shows that even at the maximum inhibitory dose of 3.0 jg ml1 CDDP, cells overcome the GO/GI and early S-phase arrest and proliferate into the 2nd, 3rd and 4th cell cycle, respectively. The quantitative data of a typical experiment from a 66 h harvest (Figure 1 GSH only slightly improved GO/GI cell activation at the highest CDDP dose. However, the rescue effect becomes more prominent at 0.15 mg ml-', and is complete at 1.5mgmlP' GSH (26.6, 32.6 and 36 .4% at 0.3, 1.0 and 3.0 tgmlm' CDDP plus GSH).
The complex alterations of the S-and G2/M-phases as indicators of cell cycle progression are shown in Figure 2 panels b and c. In comparison to the 0.3fLgmm1' CDDP treated control culture (broken line) the percentages of Sand G2/M cells decreased in both compartments at all GSH concentrations tested. In the 1.0 and 3.0 lug ml-' CDDP treated cultures the S-and G2/M-phase populations changed to control levels only at 1.5 mg ml1 GSH. The increase of S-phase cells at 0.15 mg ml' GSH in PBL's treated with 3.0 ,g ml1' CDDP is due to increased recruitment of cells from the G0/G1-population (Figure 2 panel a) , and a still incomplete rescue (e.g. slower cell cycle progression). Table I summarises the results of several experiments, and shows no significant difference of the proliferation pattern of S-and G2/M cells of CDDP/GSH treated PBL's in comparison to the control culture.
Cell killing induced by CDDP is indicated by the nuclear/ cellular decay lanes shown in Figure 1 (lower left part of the cytograms of panels c, e and g) (Kubbies, 1990b) . After addition of GSH to CDDP treated PBL's these nuclear/cellular decay lanes are significantly decreased (panels d, f and h), and are almost identical to the control cultures (panels a and b). Similar data were also obtained in studies quantitating the viable cell number characterised by its forward and right angle scatter cluster (Combrier et al., 1989 ). In the 66 h harvests there was no significant difference in the percentages 845 of viable cells between the untreated and 1.5 mg ml' GSH treated control cultures (67.8 ± 3.9 vs 71.3 ± 7.7%). At 1.0 and 3.0 iLg ml-' CDDP the percentages of viable cells decreased to 46.6 ± 4.0 and 27.9 ± 4.1%, respectively. After GSH supplementation of the culture medium of the 1.0 1g ml-' CDDP treated cells the viable cell fraction increased to 62.0 ± 5.3% (not significant compared to control levels). However, addition of GSH to the 3.0 jig ml-' CDDP treated culture increases the viable cell fraction to only 51.4 ± 8.0%. Although this is a relative increase of the viable cell population of 84% in comparison to the CDDP treated culture, it indicates that a significant cell fraction of cycling cells of about 16% died in the cell cycle progression compartments in the 1st, 2nd and/or 3rd cell cycle (GO/Gl-phase cell activation is not affected: see Table I ). Table I and Table II give evidence for a GSH induced rescue in CDDP treated cells, however, they represent different aspects of cell proliferation: the data in Table I show quantitative cell kinetic data re-calculated on the basis of cell doublings (see introductory paragraph above), whereas cell counts of Therefore calculation of absolute numbers of cell in different cell cycle compartments are invalid.
Time limited exposure of CDDP and GSH In comparison to the continuous exposure of human PBL's to CDDP, control experiments were performed exposing cells only for a limited period of time. Alteration of the cell activation process was monitored by changes of the GO/GI cell population. As shown in Figure 3 , in comparison to the untreated control cultures (broken lines) CDDP increases the non-cycling GO/GI population after a 1, 4, 20 h and con- The complexity of the inhibition of cell activation and cell cycle progression after a time limited exposure of CDDP is also reflected by the percentages of cells in subsequent cell cycles. In the untreated control culture the cell fraction in the 3rd cell cycle 66 h after PHA-activation corresponds to 37.5%, whereas after CDDP treatment (1.0 gg ml ') it decreases to 31.3%, 24.3%, 7.7% and 0. Figure 4 . In the control culture (panel a) 38.1% of the total population remained in the GO/Gl-phase, and most of the cells moved into the 2nd (Gi', S', G2/M') and 3rd cell cycle (GI", S", G2-M"). In the CDDP treated culture (3.0 igml-') most of the cells are arrested in the GO/GI-phase, and only 14.1% moved into early S-phase (panel b). In addition the nuclear debris signals increased significantly indicating massive cell death in the CDDP treated cell culture. In Figure 4 panel c the BrdU/Hoechst pattern shows that the immediate addition of GSH restores the normal cell proliferative pattern. This effect is also found when GSH is given 1 and 4 h after CDDP toxification (panel d and e). If GSH is added as late as 20 h after CDDP treatment, most of the cells remain still in the 1st cycle (panel f: G0/G1, S and G2/M). However, in comparison to the CDDP treated control culture shown in panel b the PBL's have left early S-phase, and the rescue is indicated by the fact that the cells moved completely through the S-and G2/M-phase. Moreover, 2.9% of the cells have divided once, and are recognised as Gl'-phase cells by the BrdU/Hoechst flow cytometric technique (panel f). The small number of 2nd cycle cells in the 20 h delay experiment is due to inhibition of PHA-induced cell activation processes by the prolonged CDDP exposure. This results in an increased lag-phase of the entry into the 1st cycle S-phase. However, higher percentages of 2nd and 3rd cell cycle cells are found at later harvest times (data not shown).
The quantitative data of the 66 h harvest are summarised in Figure 5 . In comparison to the 0.3 .g ml1-CDDP treated culture (broken lines in panel a) at each time point the addition of GSH decreased the non-cycling GO/Gl-fractions (% G0/GI untreated control: 38.1) and S-and G2/Mpopulations almost to control levels. The improvement of cell proliferation due to the rescue effect increases in parallel the percentages of cells in the 2nd and 3rd cycle. The rescue pattern is also present at 1.0 fig ml-' CDDP (panel b) . However, an incomplete rescue after a 20 h delayed addition of GSH is shown by the slight increased S-phase population (open bar, S-phase, panel b), which is paralleled by a smaller increase/rescue of the 2nd/3rd cell cycle population. At 3.0 jig ml-' CDDP the PBL's are completely arrested in GO/ Gl-and early S-phase (panel c, broken lines). The rescue effect is similar whether GSH is added immediately, 1 or 4 h after CDDP toxification. Although the percentage of the G0/Gl-population after a 20 h treatment decreased closely to control levels, the S-and G2/M-phase fractions are still increased due to prolonged lag-phase duration.
GSH/GSSG levels in medium
In order to evaluate possible alterations of concentrations of GSH in culture medium, HPLC analysis was applied for 
Discussion
Glutathione is an important multifunctional biomolecule which is of extensive interest in cancer chemotherapy (Arrick & Nathan, 1984; Mitchell et al., 1989; Mistry & Harrap, 1991) . In animal models and clinical studies the administration of GSH decreased nephrotoxicity and myelotoxicity (increased WBC) induced by CDDP treatment (Zunino et al., 1983; Zunino et al., 1989; Oriana et al., 1987; Di Re et al., 1990) . We investigated whether CDDP treated human PBL's can be protected by extracellular applied GSH in order to explain partially the increased WBC observed in clinical studies (Oriana et al., 1987; Di Re et al., 1990) . Most of the CDDP related cell kinetic studies performed used permanent cell lines as in vitro model systems (Salles et al., 1983; Kanno et al., 1985; Sorenson & Eastman, 1988; Fujikane et al., 1989) . However, for the investigation of severe cellular side effects induced by clastogens in vivo (Canetta et al., 1985; Mangioni et al., 1989) , normal diploid cells are the more adequate cell systems. For detailed analysis we applied a novel flow cytometric cell kinetic analysis (BrdU/Hoechst-PI technique) that is characterised by its vastly improved information about cell proliferation of heterogenous cell systems (Kubbies et al., 1987; Kubbies et al., 1989 ) and its much lower statistical variation in repeat experiments (Rabinovitch, 1983) . We show that multiple cell proliferative disturbances are induced in PBL's by CDDP. Cell activation (GO/GI) as well as cell cycle progression (S and G2/M) are inhibited in PBL's after PHA-activation. At lower CDDP concentrations the cell cycle progression inhibition in S-and G2/M is more prominent, whereas at higher doses the cell activation process and early S-phase cell cycle progression are affected. The doses of CDDP used in our experiments correspond to the range of concentrations found in the plasma of CDDP treated animals Goel et al., 1989; Sasaki et al., 1989) . Therefore similar cell kinetic disturbances might be anticipated in in vivo activated peripheral blood cells.
Treatment of cells exposed to CDDP with exogenous reduced GSH abolishes cell proliferative disturbances: (a) the activation process is no longer severely affected as indicated by normal lag-phase durations and lower percentages of non-activated GO/GI cells, and (b) the S-and G2/M-phase arrest and/or slow down disappeared as shown by normal 1st, 2nd and 3rd cell cycle distributions (Figure 2 , Table I ). A complete rescue is observed only at the highest GSH concentration of 1.5 mg ml' (equivalent to 4.9 mM) which is nontoxic to human PBL's (see also Table II for absolute cell numbers). This is a 500-fold excess of extracellular GSH in comparison to the highest dose of CDDP. However, this value is comparable to intracellular GSH concentrations of 3 to 5 mM in human leukocytes (Kosover, 1978) . In addition the effective exogenous GSH concentrations applied to whole cells in our studies is in accordance with the GSH concentration necessary to stop conversion of short-lived CDDP-DNA-monoaduct to bifunctional adducts on isolated DNA (Eastman, 1987) . These more long-lived GSH/CDDP/DNAmonoadducts might be inactivated by DNA-repair mechanisms. Therefore it is conceivable that the complete GSH rescue as late as 4 h after CDDP treatment might be explained by molecular reaction of GSH with such shortlived CDDP/DNA-monoadducts.
The time-delayed addition of GSH (1-20h) to CDDP treated cells should exclude the formal possibility of a significant direct interaction between both agents in the culture medium. As shown in Figures 4 and 5 , a 1 to 4 h delay of the addition of GSH shows a complete rescue effect. Although a 20 h delay is still effective less PBL's are found in the 2nd and 3rd cell cycle. This is simply due to the increased lag-phase duration of PHA activated PBL's induced by a 20 h CDDP treatment (delay of cell activation), and due to the washing procedure which removes the cell cycle progression factor IL-2 secreted from T-cells. It has been shown previously that (a) maximum saturation of CDDP-DNA adducts is in the range of 4 to 8 h (Eastman, 1987; Roberts & Friedlos, 1987) , and (b) a 1 to 4 h delay of the administration of cysteamine and diethyldithiocarbamate in vitro still protects cells from CDDP toxicity (Bodenner et al., 1986; Shrieve & Harris, 1982) . Our experimental results are in accordance with these data, and demonstrate that the CDDP/GSH rescue effect obviously represents a real biological phenomenon.
Preliminary experiments for intracellular quantitation of GSH using the flow cytometric monochlorobimane technique indicate that CDDP treatment of PHA-stimulated PBL's with extracellular GSH restores normal intracellular GSH and protein thiol content (data not shown). Previously it has been demonstrated that permanent human lymphoid cell lines are not permeable to extracellular GSH (Wellner et al., 1984) . Our own experimental evidence applying BSO in PBL's as an inhibitor of intracellular GSH synthesis also gave no evidence for the transport of extracellular GSH into the cells. Recent experiments suggest that glutathione ester as cell permeant molecules might decrease lethal cis-platinum toxicity in mice. However the effective dose was only 2-to 5-fold lower in comparison to GSH (Anderson et al., 1990) . However, GSH ester is taken up by all cells, and it remains to be shown whether there is selective chemoprotection or cytotoxicity on tumours or tumour cells in comparison to normal diploid cells or tissue in vivo (Zunino et al., 1983; Zunino et al., 1989; Oriana et al., 1987; Di Re et al., 1990) .
At the present we can only suggest that increased extracellular GSH levels might promote intracellular GSH-synthesis for example via increased, normally GSH-synthesis ratelimiting cyteine uptake, although at the present the intracellular effects remain obscure at the molecular level. Flow cytometric studies of intracellular GSH/thiol content in single cells applying other SH-biomolecules and inhibitors of GSH synthesis should give further insights into cellular and molecular pathways of the rescue from CDDP toxicity.
